,Set,NGenes,Direction,PValue,FDR
1,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.00123089407547931,0.500182336016796
2,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Down,0.00126071820160347,0.500182336016796
3,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,17,Down,0.0021614641633604,0.500182336016796
4,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,0.00243926634140592,0.500182336016796
5,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Down,0.00348912628359032,0.500182336016796
6,WP_IDO_METABOLIC_PATHWAY,8,Up,0.00396409433630225,0.500182336016796
7,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Down,0.00425946028238148,0.500182336016796
8,WP_OXIDATIVE_PHOSPHORYLATION,50,Down,0.00597165836187263,0.54025632880091
9,WP_MALE_INFERTILITY,68,Down,0.00674980555508915,0.54025632880091
10,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.00822659912129303,0.54025632880091
11,WP_IRON_METABOLISM_DISORDERS,10,Down,0.00865727598195726,0.54025632880091
12,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,0.00867142976396011,0.54025632880091
13,WP_MEVALONATE_PATHWAY,7,Up,0.00910969866345133,0.54025632880091
14,WP_RETINOL_METABOLISM,6,Up,0.0102656738655654,0.54025632880091
15,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Down,0.0103100586977939,0.54025632880091
16,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Down,0.010515938273497,0.54025632880091
17,WP_NUCLEOTIDE_GPCRS,5,Up,0.0114844342144386,0.555306172015798
18,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.0130760197006941,0.561630092401591
19,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,0.0135950357648601,0.561630092401591
20,WP_TP53_NETWORK,16,Down,0.0140864102164245,0.561630092401591
21,WP_IRON_METABOLISM_IN_PLACENTA,8,Down,0.0152053102474881,0.561630092401591
22,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Down,0.0153317048686318,0.561630092401591
23,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Up,0.0159459938398046,0.561630092401591
24,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,0.0163979589022362,0.561630092401591
25,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Up,0.0178272001527822,0.586158341023478
26,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,70,Up,0.0193835461098389,0.592161886573989
27,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,18,Down,0.0201122399794652,0.592161886573989
28,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Up,0.0201709645061699,0.592161886573989
29,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Down,0.0249050205225126,0.705928512741565
30,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.0262509325593845,0.719275552127136
31,WP_EFFECTS_OF_MFN2_MUTATION,18,Down,0.0284726303713493,0.722044598869246
32,WP_GDNFRET_SIGNALING_AXIS,4,Down,0.0286146480547411,0.722044598869246
33,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.0298247317329541,0.722044598869246
34,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,72,Down,0.0298655916807231,0.722044598869246
35,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.0320386535542351,0.75245066347375
36,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,40,Up,0.0341159377744937,0.778980579184272
37,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Up,0.0378870156367206,0.802838565207006
38,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.0389285109493841,0.802838565207006
39,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,0.0389649552639513,0.802838565207006
40,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Up,0.0394841640062738,0.802838565207006
41,WP_BREAST_CANCER_PATHWAY,88,Down,0.0407612741739279,0.802838565207006
42,WP_PANCREATIC_CANCER_SUBTYPES,5,Up,0.0416793342693806,0.802838565207006
43,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.0433093971190264,0.802838565207006
44,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Up,0.0442305474731713,0.802838565207006
45,WP_PILOCYTIC_ASTROCYTOMA,6,Up,0.0442846249037448,0.802838565207006
46,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Up,0.0457963064194728,0.802838565207006
47,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Down,0.0464401285950468,0.802838565207006
48,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.04795505639563,0.802838565207006
49,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.0500716657974017,0.802838565207006
50,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.0517932873232088,0.802838565207006
51,WP_DNA_DAMAGE_RESPONSE,59,Down,0.0520835646053272,0.802838565207006
52,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,77,Down,0.0523415655221974,0.802838565207006
53,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.0542401473163877,0.802838565207006
54,WP_ID_SIGNALING,12,Down,0.0544129610230548,0.802838565207006
55,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Down,0.0549818534947751,0.802838565207006
56,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Up,0.0555306060248309,0.802838565207006
57,WP_CELL_DIFFERENTIATION_INDEX,7,Up,0.0561711709439084,0.802838565207006
58,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,28,Up,0.0566479766204457,0.802838565207006
59,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.0578854240809273,0.806471501602071
60,WP_PROSTAGLANDIN_SIGNALING,22,Up,0.0616021313769582,0.807059176944437
61,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Down,0.0617240091322461,0.807059176944437
62,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.0633493644354315,0.807059176944437
63,WP_MONOAMINE_GPCRS,3,Up,0.0646954648224756,0.807059176944437
64,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.0672008531731881,0.807059176944437
65,WP_HUNGER_AND_SATIETY,2,Up,0.067478777848493,0.807059176944437
66,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Up,0.067778857990042,0.807059176944437
67,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Up,0.0689296682057003,0.807059176944437
68,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,27,Down,0.0694943369140978,0.807059176944437
69,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.0701957422967841,0.807059176944437
70,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.0714288488291009,0.807059176944437
71,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.0726977991805408,0.807059176944437
72,WP_ARYLAMINE_METABOLISM,1,Down,0.0760846352188623,0.807059176944437
73,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.0764260634683427,0.807059176944437
74,WP_TAMOXIFEN_METABOLISM,2,Down,0.0766487593859579,0.807059176944437
75,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.0777170021629135,0.807059176944437
76,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Up,0.077991244356451,0.807059176944437
77,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Down,0.0825523470269941,0.807059176944437
78,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0827337267068583,0.807059176944437
79,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.0837251462098098,0.807059176944437
80,WP_FERROPTOSIS,50,Down,0.085762321580716,0.807059176944437
81,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.088714429014019,0.807059176944437
82,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Up,0.089305012201138,0.807059176944437
83,WP_NRXN1_DELETION_SYNDROME,2,Down,0.0893178412485718,0.807059176944437
84,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.0901626089119711,0.807059176944437
85,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Up,0.0903274296508692,0.807059176944437
86,WP_ANGIOGENESIS,13,Down,0.0905146565658982,0.807059176944437
87,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Down,0.0911802625043621,0.807059176944437
88,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.0916289146960637,0.807059176944437
89,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.0916548929561488,0.807059176944437
90,WP_RAS_SIGNALING,116,Down,0.0920116015263571,0.807059176944437
91,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Down,0.0946189228109201,0.807059176944437
92,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Down,0.0949845710156468,0.807059176944437
93,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Down,0.0954078063246659,0.807059176944437
94,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.0984769039899963,0.807059176944437
95,WP_GABA_RECEPTOR_SIGNALING,9,Down,0.0993122891013309,0.807059176944437
96,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.0999566400794579,0.807059176944437
97,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.100310621507749,0.807059176944437
98,WP_IL7_SIGNALING,23,Down,0.100624196185059,0.807059176944437
99,WP_SPHINGOLIPID_PATHWAY,20,Up,0.101089701832573,0.807059176944437
100,WP_NEURAL_CREST_DIFFERENTIATION,41,Down,0.101504624777703,0.807059176944437
101,WP_ENERGY_METABOLISM,41,Up,0.101967341684291,0.807059176944437
102,WP_CCL18_SIGNALING,20,Down,0.102185417834329,0.807059176944437
103,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Down,0.102424721800425,0.807059176944437
104,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Down,0.103611379101774,0.807059176944437
105,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Up,0.103880921345034,0.807059176944437
106,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.104439655810241,0.807059176944437
107,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,46,Up,0.10505514833705,0.807059176944437
108,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Up,0.109797432031979,0.812761620984939
109,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.109814681516392,0.812761620984939
110,WP_COMPLEMENT_ACTIVATION,12,Down,0.11036625013997,0.812761620984939
111,WP_FOLATE_METABOLISM,36,Down,0.110469588677282,0.812761620984939
112,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,5,Down,0.111164264809319,0.812761620984939
113,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.111730003858027,0.812761620984939
114,WP_G13_SIGNALING,29,Up,0.114008064707842,0.822058150788123
115,WP_ATR_SIGNALING,10,Down,0.115042875999584,0.822306470188328
116,WP_ZINC_HOMEOSTASIS,21,Down,0.119177919936428,0.823994974153355
117,WP_CANCER_PATHWAYS,306,Down,0.119982951996052,0.823994974153355
118,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Down,0.120988937583482,0.823994974153355
119,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Down,0.121238116938286,0.823994974153355
120,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.121287018839558,0.823994974153355
121,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,37,Up,0.121936139361092,0.823994974153355
122,WP_SELENIUM_MICRONUTRIENT_NETWORK,49,Down,0.122296091054391,0.823994974153355
123,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,52,Down,0.123403888427002,0.824699156804844
124,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.126208884572133,0.836642767083008
125,WP_ONECARBON_METABOLISM,22,Down,0.127858363821117,0.840796600487668
126,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.128894257365821,0.840881583767502
127,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.134117675163234,0.867541816922769
128,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.13509166978846,0.867541816922769
129,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.139616067867552,0.877801545813272
130,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Up,0.140157412951328,0.877801545813272
131,WP_THERMOGENESIS,74,Up,0.140284166507806,0.877801545813272
132,WP_TRANSLATION_FACTORS,49,Up,0.140960832174394,0.877801545813272
133,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Up,0.143134261599546,0.884634308532531
134,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.146569574604457,0.890884837101823
135,WP_ERBB_SIGNALING,68,Down,0.147266091515639,0.890884837101823
136,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Down,0.147527870760744,0.890884837101823
137,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.148480806183637,0.890884837101823
138,WP_PEPTIDE_GPCRS,15,Down,0.155773288322084,0.917716437229241
139,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.155859413997898,0.917716437229241
140,WP_COPPER_HOMEOSTASIS,39,Down,0.156302069601087,0.917716437229241
141,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.159882502210271,0.920447735438075
142,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.160892725536226,0.920447735438075
143,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Down,0.161458198574683,0.920447735438075
144,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Up,0.162323385806342,0.920447735438075
145,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.162366084718395,0.920447735438075
146,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.163599253329178,0.921086207099892
147,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,22,Down,0.166704362813744,0.93218357981563
148,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Up,0.167997778577425,0.932907598676023
149,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.169103688811104,0.932907598676023
150,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Down,0.173040195187178,0.935797353419939
151,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Up,0.173856110203864,0.935797353419939
152,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Up,0.174977004448852,0.935797353419939
153,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.175390564917958,0.935797353419939
154,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,49,Up,0.176523392526554,0.935797353419939
155,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.17751354380935,0.935797353419939
156,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Down,0.183803875720614,0.935797353419939
157,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Up,0.184339124469159,0.935797353419939
158,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.188995297841649,0.935797353419939
159,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Up,0.189114531819463,0.935797353419939
160,WP_IL3_SIGNALING,46,Up,0.191496808831784,0.935797353419939
161,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.194336355845946,0.935797353419939
162,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.195273524095327,0.935797353419939
163,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Down,0.195540631772828,0.935797353419939
164,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Down,0.195558343126597,0.935797353419939
165,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.196668154041176,0.935797353419939
166,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Down,0.197596098413689,0.935797353419939
167,WP_PPARALPHA_PATHWAY,15,Down,0.197988666627921,0.935797353419939
168,WP_DOPAMINE_METABOLISM,7,Down,0.201828312315213,0.935797353419939
169,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.201828511107703,0.935797353419939
170,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.201851933405191,0.935797353419939
171,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Down,0.20659189879208,0.935797353419939
172,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Down,0.207164511076823,0.935797353419939
173,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,61,Down,0.207679807486585,0.935797353419939
174,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Down,0.208999290960353,0.935797353419939
175,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Up,0.209083769186832,0.935797353419939
176,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Up,0.211738433522355,0.935797353419939
177,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.213027286686503,0.935797353419939
178,WP_HIPPOYAP_SIGNALING,16,Down,0.213193166237904,0.935797353419939
179,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.214321648207854,0.935797353419939
180,WP_ESTROGEN_SIGNALING,21,Down,0.214416331829898,0.935797353419939
181,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.215631603448747,0.935797353419939
182,WP_SMALL_LIGAND_GPCRS,7,Down,0.21571768636004,0.935797353419939
183,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.218750148833967,0.935797353419939
184,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Down,0.220759402654585,0.935797353419939
185,WP_ENDOMETRIAL_CANCER,49,Down,0.221749090918259,0.935797353419939
186,WP_IL4_SIGNALING,50,Up,0.222097848831608,0.935797353419939
187,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Down,0.223243277583982,0.935797353419939
188,WP_BURN_WOUND_HEALING,60,Down,0.225604387224982,0.935797353419939
189,WP_GALANIN_RECEPTOR_PATHWAY,10,Down,0.226656182213149,0.935797353419939
190,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.226762644600511,0.935797353419939
191,WP_ALPHA_6_BETA_4_SIGNALING,26,Up,0.226942079040123,0.935797353419939
192,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Up,0.227267677581988,0.935797353419939
193,WP_CHOLESTASIS,9,Down,0.227680120169151,0.935797353419939
194,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,33,Down,0.228936205551038,0.935797353419939
195,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.228949283911994,0.935797353419939
196,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Down,0.232556406913344,0.935797353419939
197,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,66,Down,0.232986913503756,0.935797353419939
198,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Down,0.233491686668707,0.935797353419939
199,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.234461052379117,0.935797353419939
200,WP_ALSTROM_SYNDROME,27,Down,0.235184467905147,0.935797353419939
201,WP_LEPTIN_SIGNALING,69,Up,0.235506333107963,0.935797353419939
202,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,87,Down,0.237281983070645,0.935797353419939
203,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.237929527144749,0.935797353419939
204,WP_FRAGILE_X_SYNDROME,83,Up,0.238472870097328,0.935797353419939
205,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,63,Down,0.238620033813793,0.935797353419939
206,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Up,0.241223922258823,0.935797353419939
207,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Up,0.242083891043212,0.935797353419939
208,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.242658256352943,0.935797353419939
209,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Up,0.243887538872652,0.935797353419939
210,WP_VITAMIN_B12_METABOLISM,23,Down,0.243898636675238,0.935797353419939
211,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Up,0.24432061446565,0.935797353419939
212,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.245359543167753,0.935797353419939
213,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.247664170637616,0.935797353419939
214,WP_NUCLEAR_RECEPTORS_METAPATHWAY,177,Down,0.248408339579392,0.935797353419939
215,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.253297141027504,0.935797353419939
216,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.254232846234681,0.935797353419939
217,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.254594125249532,0.935797353419939
218,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.255458427640722,0.935797353419939
219,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.256472450525216,0.935797353419939
220,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Up,0.257214503262636,0.935797353419939
221,WP_MONOAMINE_TRANSPORT,11,Up,0.258581813619628,0.935797353419939
222,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.260172054851486,0.935797353419939
223,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.260904624798597,0.935797353419939
224,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.261022227142507,0.935797353419939
225,WP_SERINE_METABOLISM,5,Down,0.261424085639417,0.935797353419939
226,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.26168958936045,0.935797353419939
227,WP_PRION_DISEASE_PATHWAY,28,Down,0.262369559335929,0.935797353419939
228,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Down,0.263360165456827,0.935797353419939
229,WP_MAPK_SIGNALING,161,Down,0.263549205020328,0.935797353419939
230,WP_APOPTOSIS,72,Down,0.264932318912132,0.935797353419939
231,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Down,0.266086722249672,0.935797353419939
232,WP_EICOSANOID_SYNTHESIS,13,Down,0.267926161670047,0.935797353419939
233,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Down,0.269571347682932,0.935797353419939
234,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.270178452788154,0.935797353419939
235,WP_P38_MAPK_SIGNALING,31,Up,0.270964935360256,0.935797353419939
236,WP_HEDGEHOG_SIGNALING_WP47,6,Down,0.272778409173951,0.935797353419939
237,WP_SPINAL_CORD_INJURY,66,Down,0.274067221677341,0.935797353419939
238,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.275238494866242,0.935797353419939
239,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.275351946580248,0.935797353419939
240,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Up,0.276728411814757,0.935797353419939
241,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.277962794857171,0.935797353419939
242,WP_ALLOGRAFT_REJECTION,50,Down,0.279029765765342,0.935797353419939
243,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,14,Down,0.279953322700026,0.935797353419939
244,WP_MELANOMA,55,Down,0.281429276083477,0.935797353419939
245,WP_AGERAGE_PATHWAY,54,Down,0.281627980197797,0.935797353419939
246,WP_APOPTOSIS_MODULATION_AND_SIGNALING,77,Down,0.281965817154472,0.935797353419939
247,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.286163861562851,0.935797353419939
248,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Up,0.28715169092914,0.935797353419939
249,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.287506402700792,0.935797353419939
250,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.287645008081728,0.935797353419939
251,WP_STEROID_BIOSYNTHESIS,3,Down,0.288532855141447,0.935797353419939
252,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.289618121453816,0.935797353419939
253,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.290436209791156,0.935797353419939
254,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.292037066526846,0.935797353419939
255,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Down,0.292599804856324,0.935797353419939
256,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,48,Up,0.292927285715981,0.935797353419939
257,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Up,0.293892001309845,0.935797353419939
258,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Down,0.294343651052623,0.935797353419939
259,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Down,0.295097329940743,0.935797353419939
260,WP_MESODERMAL_COMMITMENT_PATHWAY,77,Down,0.29599429670217,0.935797353419939
261,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.298213331719659,0.936236810829132
262,WP_TRYPTOPHAN_METABOLISM,19,Up,0.298411246274006,0.936236810829132
263,WP_SEROTONIN_AND_ANXIETY,7,Down,0.302100033083446,0.944206187051682
264,WP_PARKINSONS_DISEASE_PATHWAY,27,Down,0.308398088374178,0.960239502437781
265,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Up,0.313127480249394,0.961994190111393
266,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Up,0.313263140311463,0.961994190111393
267,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.313872225636285,0.961994190111393
268,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.314107292971898,0.961994190111393
269,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.316858793685923,0.961994190111393
270,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,34,Up,0.318157524922872,0.961994190111393
271,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,93,Down,0.319686249025896,0.961994190111393
272,WP_GLYOXYLATE_METABOLISM,5,Up,0.320081303204216,0.961994190111393
273,WP_TAR_SYNDROME,43,Up,0.320494323308409,0.961994190111393
274,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,22,Down,0.320664730037131,0.961994190111393
275,WP_IL1_SIGNALING,52,Up,0.326670391591362,0.97247767303077
276,WP_POSTCOVID_NEUROINFLAMMATION,11,Up,0.328427577150947,0.97247767303077
277,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.331307493241735,0.97247767303077
278,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.333420287570412,0.97247767303077
279,WP_GLUCURONIDATION,7,Down,0.334770886867271,0.97247767303077
280,WP_CHOLESTEROL_METABOLISM,53,Up,0.334905627604025,0.97247767303077
281,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.335391944302478,0.97247767303077
282,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.335711955720416,0.97247767303077
283,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Up,0.336177476972438,0.97247767303077
284,WP_NOTCH_SIGNALING_WP268,35,Down,0.337178328549677,0.97247767303077
285,WP_BIOGENIC_AMINE_SYNTHESIS,1,Down,0.34031071789345,0.97247767303077
286,WP_NEUROTRANSMITTER_DISORDERS,1,Down,0.34031071789345,0.97247767303077
287,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.341712071089988,0.97247767303077
288,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Up,0.342952459051911,0.97247767303077
289,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Down,0.343616357788906,0.97247767303077
290,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.344394664673715,0.97247767303077
291,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Up,0.345978967692203,0.97247767303077
292,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.346632698793007,0.97247767303077
293,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.346637418732379,0.97247767303077
294,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.348643553823056,0.974778915790993
295,WP_PREIMPLANTATION_EMBRYO,21,Down,0.351057301804086,0.976862883371305
296,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.351765709827137,0.976862883371305
297,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Up,0.353328703001087,0.977192455996496
298,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.35506933058681,0.977192455996496
299,WP_GPCRS_OTHER,12,Up,0.356328722259818,0.977192455996496
300,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.356639582480473,0.977192455996496
301,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.358790508520718,0.978651933171166
302,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.363176930086562,0.978651933171166
303,WP_FOXA2_PATHWAY,9,Down,0.366220242823403,0.978651933171166
304,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.369713435728013,0.978651933171166
305,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Down,0.37106052851311,0.978651933171166
306,WP_INTERFERON_TYPE_I_SIGNALING,50,Up,0.372986701043377,0.978651933171166
307,WP_13Q1212_COPY_NUMBER_VARIATION,20,Up,0.373690037374598,0.978651933171166
308,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.374422067282886,0.978651933171166
309,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.375212024289459,0.978651933171166
310,WP_AEROBIC_GLYCOLYSIS,10,Down,0.376489556499592,0.978651933171166
311,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Down,0.376489556499592,0.978651933171166
312,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Down,0.376611671004337,0.978651933171166
313,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.376732645584796,0.978651933171166
314,WP_WNT_SIGNALING_WP428,59,Down,0.379223086527097,0.978651933171166
315,WP_INTEGRATED_CANCER_PATHWAY,41,Down,0.380029749082269,0.978651933171166
316,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Down,0.38401712475892,0.978651933171166
317,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,49,Up,0.384189240621712,0.978651933171166
318,WP_EPO_RECEPTOR_SIGNALING,23,Down,0.386277084861357,0.978651933171166
319,WP_TGFB_SMAD_SIGNALING,7,Up,0.38731622754368,0.978651933171166
320,WP_SYNAPTIC_VESICLE_PATHWAY,22,Down,0.388648342804178,0.978651933171166
321,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.388785100203665,0.978651933171166
322,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.391477109840844,0.978651933171166
323,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,30,Down,0.391729540016968,0.978651933171166
324,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.394178609013834,0.978651933171166
325,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Down,0.394579794664043,0.978651933171166
326,WP_MAPK_CASCADE,30,Down,0.395614524106515,0.978651933171166
327,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Down,0.395779151108891,0.978651933171166
328,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Down,0.398990376792093,0.978651933171166
329,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.399524757050345,0.978651933171166
330,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.400952897706189,0.978651933171166
331,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,32,Up,0.404860400428687,0.978651933171166
332,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Down,0.406858488058299,0.978651933171166
333,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Down,0.407043549060027,0.978651933171166
334,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.407859440169489,0.978651933171166
335,WP_GASTRIC_CANCER_NETWORK_1,18,Up,0.409122029810458,0.978651933171166
336,WP_TRANSSULFURATION_PATHWAY,8,Up,0.41004154848993,0.978651933171166
337,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Up,0.410090279999673,0.978651933171166
338,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Up,0.412579337020934,0.978651933171166
339,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.413549313549098,0.978651933171166
340,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.414384584778337,0.978651933171166
341,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,61,Down,0.415126559647712,0.978651933171166
342,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Down,0.41741725998737,0.978651933171166
343,WP_PRIMARY_OVARIAN_INSUFFICIENCY,88,Down,0.421385086733927,0.978651933171166
344,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Down,0.426940640701256,0.978651933171166
345,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Down,0.426953834222143,0.978651933171166
346,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Down,0.427094332563864,0.978651933171166
347,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Down,0.427346831441129,0.978651933171166
348,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Up,0.431127755024922,0.978651933171166
349,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Up,0.434033457543048,0.978651933171166
350,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Down,0.436190262432653,0.978651933171166
351,WP_NAD_METABOLISM,12,Up,0.436879300624775,0.978651933171166
352,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,77,Down,0.438756944482609,0.978651933171166
353,WP_BASE_EXCISION_REPAIR,29,Down,0.439804854282826,0.978651933171166
354,WP_SMALL_CELL_LUNG_CANCER,70,Down,0.441181168709394,0.978651933171166
355,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.44183919364397,0.978651933171166
356,WP_KININKALLIKREIN_PATHWAY,2,Down,0.442257650819029,0.978651933171166
357,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,10,Down,0.442629169408965,0.978651933171166
358,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.44661687604189,0.978651933171166
359,WP_HYPERTROPHY_MODEL,12,Up,0.446814039798381,0.978651933171166
360,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.447186387681988,0.978651933171166
361,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.450195708069644,0.978651933171166
362,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.452690507530599,0.978651933171166
363,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.453401717301751,0.978651933171166
364,WP_NETRINUNC5B_SIGNALING,35,Down,0.454856120225905,0.978651933171166
365,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Down,0.457359807226122,0.978651933171166
366,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Down,0.458223090395761,0.978651933171166
367,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.459239965156038,0.978651933171166
368,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.45961308129607,0.978651933171166
369,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Down,0.463627158951545,0.978651933171166
370,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.466327788305338,0.978651933171166
371,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.467284992717116,0.978651933171166
372,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.467416596221789,0.978651933171166
373,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Down,0.467966788544989,0.978651933171166
374,WP_HEME_BIOSYNTHESIS,8,Down,0.467966788544989,0.978651933171166
375,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Down,0.468209549008451,0.978651933171166
376,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.468897643075941,0.978651933171166
377,WP_COMPLEMENT_SYSTEM,51,Down,0.469523161109435,0.978651933171166
378,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.470469487641933,0.978651933171166
379,WP_VITAMIN_D_RECEPTOR_PATHWAY,83,Down,0.47217382373949,0.978651933171166
380,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Down,0.472851538934034,0.978651933171166
381,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Up,0.474065905031193,0.978651933171166
382,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Up,0.474680047044813,0.978651933171166
383,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Down,0.475545932787203,0.978651933171166
384,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Up,0.476432683816275,0.978651933171166
385,WP_EGFEGFR_SIGNALING,138,Down,0.476984708295915,0.978651933171166
386,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,15,Up,0.477237831191778,0.978651933171166
387,WP_PURINERGIC_SIGNALING,15,Up,0.477816207947565,0.978651933171166
388,WP_IL5_SIGNALING,37,Up,0.480527612150633,0.978651933171166
389,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Up,0.482702845075369,0.978651933171166
390,WP_NPHP1_DELETION_SYNDROME,10,Up,0.483572442106223,0.978651933171166
391,WP_CORI_CYCLE,11,Down,0.484217428065272,0.978651933171166
392,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Down,0.485962167409496,0.978651933171166
393,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.488633123873318,0.978651933171166
394,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.489858921470265,0.978651933171166
395,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.494059127009372,0.978651933171166
396,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.496017338139098,0.978651933171166
397,WP_MEASLES_VIRUS_INFECTION,100,Up,0.496131536296472,0.978651933171166
398,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.497337903496606,0.978651933171166
399,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Down,0.497405835345174,0.978651933171166
400,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.497645771483664,0.978651933171166
401,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Up,0.501312460179152,0.978651933171166
402,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Down,0.502574336420561,0.978651933171166
403,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.503213051864027,0.978651933171166
404,WP_OSTEOPONTIN_SIGNALING,11,Up,0.504111855068557,0.978651933171166
405,WP_FOXP3_IN_COVID19,9,Down,0.511155770378297,0.978651933171166
406,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Down,0.513130762450679,0.978651933171166
407,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.513333819940761,0.978651933171166
408,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Up,0.515907446545324,0.978651933171166
409,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,48,Down,0.51625684860646,0.978651933171166
410,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Up,0.517236998712534,0.978651933171166
411,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.520138865007832,0.978651933171166
412,WP_NRF2_PATHWAY,72,Down,0.521041404971207,0.978651933171166
413,WP_CAMKK2_PATHWAY,29,Down,0.523595015217424,0.978651933171166
414,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.523848289063864,0.978651933171166
415,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Up,0.525696429984273,0.978651933171166
416,WP_CREATINE_PATHWAY,2,Up,0.527812249882397,0.978651933171166
417,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.52920384620104,0.978651933171166
418,WP_OREXIN_RECEPTOR_PATHWAY,119,Up,0.530024592326009,0.978651933171166
419,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.531108649435958,0.978651933171166
420,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.532160599526602,0.978651933171166
421,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.533298295593135,0.978651933171166
422,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Down,0.536207718239601,0.978651933171166
423,WP_G_PROTEIN_SIGNALING,62,Down,0.536575829087186,0.978651933171166
424,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.538054729969857,0.978651933171166
425,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.538590637778515,0.978651933171166
426,WP_HEDGEHOG_SIGNALING_WP4249,25,Up,0.540914408152536,0.978651933171166
427,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.541972475284755,0.978651933171166
428,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.543552576237555,0.978651933171166
429,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.543552576237555,0.978651933171166
430,WP_NEOVASCULARIZATION_PROCESSES,22,Down,0.547826027978698,0.978651933171166
431,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Down,0.549735050287512,0.978651933171166
432,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.550179918286309,0.978651933171166
433,WP_SLEEP_REGULATION,11,Up,0.550216968592762,0.978651933171166
434,WP_PPAR_SIGNALING,39,Down,0.550337165975967,0.978651933171166
435,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Up,0.551319274845788,0.978651933171166
436,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Down,0.551459878189434,0.978651933171166
437,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.551486039282251,0.978651933171166
438,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.552600411481652,0.978651933171166
439,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Up,0.553297836490988,0.978651933171166
440,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.555141633025431,0.978651933171166
441,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,52,Down,0.555522344775257,0.978651933171166
442,WP_HEART_DEVELOPMENT,16,Down,0.55589830696606,0.978651933171166
443,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Up,0.555965420550137,0.978651933171166
444,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.556690465948266,0.978651933171166
445,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.559105955932143,0.978651933171166
446,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,136,Down,0.559223804361238,0.978651933171166
447,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Up,0.560617591871104,0.978651933171166
448,WP_16P112_DISTAL_DELETION_SYNDROME,20,Down,0.560754180234986,0.978651933171166
449,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.564180743261423,0.978651933171166
450,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Down,0.564342082549425,0.978651933171166
451,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Down,0.564342082549425,0.978651933171166
452,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Down,0.564528512024765,0.978651933171166
453,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.566204961266625,0.978651933171166
454,WP_CALORIC_RESTRICTION_AND_AGING,7,Down,0.569888871805039,0.978651933171166
455,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Up,0.570167857212067,0.978651933171166
456,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.570947130513654,0.978651933171166
457,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Down,0.571056256039482,0.978651933171166
458,WP_NEUROINFLAMMATION,10,Up,0.571292457901244,0.978651933171166
459,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,11,Down,0.572220018341416,0.978651933171166
460,WP_SULFATASE_AND_AROMATASE_PATHWAY,4,Down,0.573377773132262,0.978651933171166
461,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.574043428804607,0.978651933171166
462,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Down,0.574204909424721,0.978651933171166
463,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.574341255712854,0.978651933171166
464,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.575866776954231,0.978651933171166
465,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.576365856613733,0.978651933171166
466,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.581558885214931,0.978651933171166
467,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Up,0.581608811706329,0.978651933171166
468,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.583521126536285,0.978651933171166
469,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.583858420962329,0.978651933171166
470,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Up,0.583991275940909,0.978651933171166
471,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.585383736281186,0.978651933171166
472,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.585481708023976,0.978651933171166
473,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Down,0.588700508511044,0.978651933171166
474,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Down,0.5887398907524,0.978651933171166
475,WP_IL18_SIGNALING,189,Down,0.591159346069565,0.978651933171166
476,WP_TYPE_III_INTERFERON_SIGNALING,7,Up,0.591728437250499,0.978651933171166
477,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.594848830503375,0.978651933171166
478,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.594975327712321,0.978651933171166
479,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.595197558229496,0.978651933171166
480,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Up,0.597016171022447,0.978651933171166
481,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Down,0.597149515062928,0.978651933171166
482,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Up,0.598565237343726,0.978651933171166
483,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Up,0.599037359021093,0.978651933171166
484,WP_IL17_SIGNALING,25,Up,0.599793661522426,0.978651933171166
485,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.600147623176897,0.978651933171166
486,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,25,Down,0.601054837132128,0.978651933171166
487,WP_DOPAMINERGIC_NEUROGENESIS,4,Up,0.602445933741917,0.978651933171166
488,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,14,Up,0.605430948051313,0.978651933171166
489,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Down,0.607271595407351,0.978651933171166
490,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.608303085616179,0.978651933171166
491,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.610306951527085,0.978651933171166
492,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.611787056560614,0.978651933171166
493,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Up,0.612531964864857,0.978651933171166
494,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.613877026082435,0.978651933171166
495,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.614180884017584,0.978651933171166
496,WP_BENZENE_METABOLISM,3,Down,0.614721388332516,0.978651933171166
497,WP_RETT_SYNDROME,31,Up,0.616343494159027,0.978651933171166
498,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.616414094842358,0.978651933171166
499,WP_BLADDER_CANCER,29,Down,0.617275757401467,0.978651933171166
500,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.617547189678693,0.978651933171166
501,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,45,Down,0.618433401020088,0.978651933171166
502,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Up,0.619771354451411,0.978651933171166
503,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Down,0.619827036248548,0.978651933171166
504,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.620051941303228,0.978651933171166
505,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.620078311131059,0.978651933171166
506,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.621826518797536,0.978651933171166
507,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.622064036036246,0.978651933171166
508,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.622820704184674,0.978651933171166
509,WP_VITAMIN_B12_DISORDERS,9,Up,0.622879776515053,0.978651933171166
510,WP_MTHFR_DEFICIENCY,18,Down,0.623400236700483,0.978651933171166
511,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.626357307290729,0.978651933171166
512,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Up,0.626384908208941,0.978651933171166
513,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.627091329311635,0.978651933171166
514,WP_5Q35_COPY_NUMBER_VARIATION,76,Down,0.627109206103958,0.978651933171166
515,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.627116064255052,0.978651933171166
516,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.628071900814436,0.978651933171166
517,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Up,0.628535162404167,0.978651933171166
518,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.629055577909874,0.978651933171166
519,WP_NEPHROTIC_SYNDROME,27,Down,0.629962794974569,0.978651933171166
520,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.631893898723912,0.978651933171166
521,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.632207112536768,0.978651933171166
522,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.634260535244428,0.978651933171166
523,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.634684905689269,0.978651933171166
524,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.638729424040761,0.978651933171166
525,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.639680459274726,0.978651933171166
526,WP_BENZOAPYRENE_METABOLISM,5,Down,0.641954111442163,0.978651933171166
527,WP_VALPROIC_ACID_PATHWAY,9,Up,0.643504570684659,0.978651933171166
528,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.644861604770297,0.978651933171166
529,WP_OVARIAN_INFERTILITY,21,Up,0.645503207680974,0.978651933171166
530,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.646739462044734,0.978651933171166
531,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.648290575261903,0.978651933171166
532,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.649956653538272,0.978651933171166
533,WP_IL26_SIGNALING,31,Up,0.652275490941421,0.978651933171166
534,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.652333457699805,0.978651933171166
535,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.652356189553769,0.978651933171166
536,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,84,Down,0.653759023960624,0.978651933171166
537,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.654512253269852,0.978651933171166
538,WP_CILIOPATHIES,127,Up,0.655736741070539,0.978651933171166
539,WP_AXON_GUIDANCE,38,Down,0.656009956992312,0.978651933171166
540,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Up,0.65634217851892,0.978651933171166
541,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Up,0.661721203374025,0.978651933171166
542,WP_ENDODERM_DIFFERENTIATION,84,Down,0.661873779170051,0.978651933171166
543,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.661945902097451,0.978651933171166
544,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Down,0.661945902097451,0.978651933171166
545,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.662657783204738,0.978651933171166
546,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,72,Up,0.666046985303749,0.978651933171166
547,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.667855358458566,0.978651933171166
548,WP_CHEMOKINE_SIGNALING,110,Up,0.670257042269737,0.978651933171166
549,WP_PDGF_PATHWAY,36,Up,0.672355796881783,0.978651933171166
550,WP_NEPHROGENESIS,4,Up,0.672375181828087,0.978651933171166
551,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.676425703152749,0.978651933171166
552,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.677724729721517,0.978651933171166
553,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Up,0.678926301650286,0.978651933171166
554,WP_PLEURAL_MESOTHELIOMA,254,Down,0.680327086477464,0.978651933171166
555,WP_GPR40_PATHWAY,8,Down,0.682193725458355,0.978651933171166
556,WP_GASTRIN_SIGNALING,92,Down,0.682416634952987,0.978651933171166
557,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Up,0.683098051466869,0.978651933171166
558,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Down,0.685386851328683,0.978651933171166
559,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.685485666732609,0.978651933171166
560,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Down,0.687258682629733,0.978651933171166
561,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Down,0.687798702230396,0.978651933171166
562,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.689463248218293,0.978651933171166
563,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Down,0.690111501065212,0.978651933171166
564,WP_ACUTE_MYELOID_LEUKEMIA,55,Down,0.691425441440509,0.978651933171166
565,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,80,Down,0.692878110776009,0.978651933171166
566,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.697422000012508,0.978651933171166
567,WP_TYPE_II_DIABETES_MELLITUS,14,Up,0.699334398635547,0.978651933171166
568,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Up,0.70005947073328,0.978651933171166
569,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.700297591267107,0.978651933171166
570,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Up,0.700540034466171,0.978651933171166
571,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.702216743590585,0.978651933171166
572,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.703020401471647,0.978651933171166
573,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Down,0.703693494277186,0.978651933171166
574,WP_PI3KAKT_SIGNALING,178,Down,0.703721874485692,0.978651933171166
575,WP_HOMOLOGOUS_RECOMBINATION,11,Up,0.70507770744501,0.978651933171166
576,WP_ECTODERM_DIFFERENTIATION,78,Down,0.705329861686906,0.978651933171166
577,WP_KREBS_CYCLE_DISORDERS,11,Up,0.706050705572348,0.978651933171166
578,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.706456988158787,0.978651933171166
579,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.706842449306451,0.978651933171166
580,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Down,0.707814303321239,0.978651933171166
581,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.708022192148032,0.978651933171166
582,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.709985914228951,0.978651933171166
583,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.710406833424731,0.978651933171166
584,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.711663601123191,0.978651933171166
585,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.712609184438892,0.978651933171166
586,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.713628341083195,0.978651933171166
587,WP_OSTEOCLAST_SIGNALING,9,Up,0.714285955593209,0.978651933171166
588,WP_G1_TO_S_CELL_CYCLE_CONTROL,52,Up,0.716448420501111,0.978651933171166
589,WP_MATRIX_METALLOPROTEINASES,8,Down,0.719121647682611,0.978651933171166
590,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.719256393363247,0.978651933171166
591,WP_SULINDAC_METABOLIC_PATHWAY,2,Up,0.722592164269676,0.978651933171166
592,WP_HIPPO_SIGNALING_REGULATION,44,Up,0.722855499408161,0.978651933171166
593,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.724144860633929,0.978651933171166
594,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.724471282588356,0.978651933171166
595,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.724729895009124,0.978651933171166
596,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Down,0.72521250467271,0.978651933171166
597,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.725291019698381,0.978651933171166
598,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.727204529504399,0.978651933171166
599,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.727561142267757,0.978651933171166
600,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.727913742580571,0.978651933171166
601,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.728192903328254,0.978651933171166
602,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.728374434181679,0.978651933171166
603,WP_OSTEOBLAST_SIGNALING,3,Down,0.728427934910567,0.978651933171166
604,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Up,0.729008906162075,0.978651933171166
605,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.729220848325086,0.978651933171166
606,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,166,Down,0.729418203146126,0.978651933171166
607,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.729871172814203,0.978651933171166
608,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Down,0.729930821373311,0.978651933171166
609,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Up,0.730830225674894,0.978651933171166
610,WP_TARGET_OF_RAPAMYCIN_SIGNALING,33,Up,0.732902526475858,0.978651933171166
611,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Down,0.732981154816147,0.978651933171166
612,WP_VEGFAVEGFR2_SIGNALING,340,Down,0.733376033157197,0.978651933171166
613,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.733458805666907,0.978651933171166
614,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.733916920325379,0.978651933171166
615,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.734019055083538,0.978651933171166
616,WP_VITAMIN_D_METABOLISM,6,Down,0.734366887419506,0.978651933171166
617,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.734584236942348,0.978651933171166
618,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.740720766244166,0.983589490738103
619,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.741607827754515,0.983589490738103
620,WP_ENDOTHELIN_PATHWAYS,12,Down,0.743346381980673,0.983589490738103
621,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,106,Up,0.744377562895369,0.983589490738103
622,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.746055090620624,0.983589490738103
623,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.748295337785389,0.983589490738103
624,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Down,0.749244543171736,0.983589490738103
625,WP_MRNA_PROCESSING,124,Up,0.750470450536305,0.983589490738103
626,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Up,0.754729494239895,0.983589490738103
627,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,0.756953542647208,0.983589490738103
628,WP_RANKLRANK_SIGNALING,47,Up,0.757696730799573,0.983589490738103
629,WP_LUNG_PATHOLOGY_OF_COVID19,14,Down,0.758018705984847,0.983589490738103
630,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.758055397177832,0.983589490738103
631,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.758231311070673,0.983589490738103
632,WP_LUNG_FIBROSIS,33,Up,0.760311911746677,0.983589490738103
633,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.760675799392779,0.983589490738103
634,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Down,0.761682678994479,0.983589490738103
635,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.76400978607928,0.983589490738103
636,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Down,0.767536835796348,0.983589490738103
637,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.768574186457003,0.983589490738103
638,WP_NUCLEAR_RECEPTORS,20,Up,0.770348068074875,0.983589490738103
639,WP_NOTCH_SIGNALING_WP61,49,Down,0.770647511135381,0.983589490738103
640,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Down,0.771631706435295,0.983589490738103
641,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.772750842998292,0.983589490738103
642,WP_IRINOTECAN_PATHWAY,5,Up,0.774358176950371,0.983589490738103
643,WP_METHYLATION_PATHWAYS,5,Down,0.776495446743438,0.983589490738103
644,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Up,0.776833571701295,0.983589490738103
645,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.780642364375196,0.983589490738103
646,WP_INSULIN_SIGNALING,130,Down,0.782052933212227,0.983589490738103
647,WP_IL2_SIGNALING,37,Up,0.782076247820726,0.983589490738103
648,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Down,0.783621373503038,0.983589490738103
649,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.784103616418881,0.983589490738103
650,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.784780940141296,0.983589490738103
651,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.786537737294226,0.983589490738103
652,WP_15Q11Q13_COPY_NUMBER_VARIATION,35,Up,0.787821033526441,0.983589490738103
653,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.79396692576338,0.983589490738103
654,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Down,0.795294427809677,0.983589490738103
655,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.797351919614631,0.983589490738103
656,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,90,Up,0.798272465743255,0.983589490738103
657,WP_PURINE_METABOLISM,10,Up,0.799906370039611,0.983589490738103
658,WP_PDGFRBETA_PATHWAY,27,Up,0.800372955457174,0.983589490738103
659,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.800885163742879,0.983589490738103
660,WP_PROTEASOME_DEGRADATION,57,Up,0.801019085593935,0.983589490738103
661,WP_ALZHEIMERS_DISEASE,184,Up,0.801729769551,0.983589490738103
662,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.801729769551,0.983589490738103
663,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.802529733010724,0.983589490738103
664,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.805320908173453,0.983589490738103
665,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Up,0.805372931918613,0.983589490738103
666,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.805959850859702,0.983589490738103
667,WP_SPINA_BIFIDA,10,Up,0.806473238704239,0.983589490738103
668,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.807303012478505,0.983589490738103
669,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,18,Down,0.808220215728947,0.983589490738103
670,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.808545487500109,0.983589490738103
671,WP_CELL_CYCLE,95,Down,0.808919251677223,0.983589490738103
672,WP_SEROTONIN_TRANSPORTER_ACTIVITY,3,Up,0.810465766398272,0.983589490738103
673,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Down,0.811005728551693,0.983589490738103
674,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.81853856113378,0.983589490738103
675,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.819315901643765,0.983589490738103
676,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.81945624767375,0.983589490738103
677,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.821574512596344,0.983589490738103
678,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.821574512596344,0.983589490738103
679,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,126,Down,0.821600461049326,0.983589490738103
680,WP_DNA_MISMATCH_REPAIR,21,Down,0.824621078975167,0.983589490738103
681,WP_TNFALPHA_SIGNALING,84,Up,0.825399169627131,0.983589490738103
682,WP_GPCRS_CLASS_A_RHODOPSINLIKE,43,Down,0.826546963625342,0.983589490738103
683,WP_CELLULAR_PROTEOSTASIS,6,Up,0.826800519771023,0.983589490738103
684,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.827706149232945,0.983589490738103
685,WP_PYRIMIDINE_METABOLISM,71,Down,0.829577723005975,0.983589490738103
686,WP_GASTRIC_CANCER_NETWORK_2,26,Up,0.829934874192212,0.983589490738103
687,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Up,0.832993898172204,0.983589490738103
688,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Down,0.8330751034273,0.983589490738103
689,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.833509382399984,0.983589490738103
690,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.836407956893376,0.983589490738103
691,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.837618837876877,0.983589490738103
692,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Down,0.83790836548294,0.983589490738103
693,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Down,0.838753305383045,0.983589490738103
694,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.839855708920923,0.983589490738103
695,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.843924568625018,0.983589490738103
696,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.845198597034302,0.983589490738103
697,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.845321565861144,0.983589490738103
698,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.846125590669076,0.983589490738103
699,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.84882586237513,0.983589490738103
700,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.850339186403465,0.983589490738103
701,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.852009573685057,0.983589490738103
702,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,38,Up,0.855422935903386,0.983589490738103
703,WP_SILDENAFIL_TREATMENT,11,Down,0.856821764207005,0.983589490738103
704,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.857095085357658,0.983589490738103
705,WP_TCELL_RECEPTOR_SIGNALING,72,Up,0.857818207553241,0.983589490738103
706,WP_LIPID_PARTICLES_COMPOSITION,5,Down,0.858842599681022,0.983589490738103
707,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Down,0.859139616055898,0.983589490738103
708,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.859206598346254,0.983589490738103
709,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.860294778241208,0.983589490738103
710,WP_IL19_SIGNALING,20,Up,0.862348964426851,0.983589490738103
711,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.862635390348675,0.983589490738103
712,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Up,0.863352036777568,0.983589490738103
713,WP_TGFBETA_RECEPTOR_SIGNALING,35,Up,0.864151864877522,0.983589490738103
714,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.864906623726317,0.983589490738103
715,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.865027051530207,0.983589490738103
716,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Down,0.865238149408016,0.983589490738103
717,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.86595262497065,0.983589490738103
718,WP_TCELL_ACTIVATION_SARSCOV2,60,Down,0.866110818509491,0.983589490738103
719,WP_ONCOSTATIN_M_SIGNALING,55,Up,0.866510541543897,0.983589490738103
720,WP_KIT_RECEPTOR_SIGNALING,51,Up,0.867190424671373,0.983589490738103
721,WP_WNT_SIGNALING_WP363,38,Down,0.8692193873569,0.983589490738103
722,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.872156287357933,0.983589490738103
723,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,15,Down,0.872401250346271,0.983589490738103
724,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Up,0.8735373973816,0.983589490738103
725,WP_KALLMANN_SYNDROME,11,Down,0.874240438583095,0.983589490738103
726,WP_DNA_REPLICATION,36,Up,0.874746021596834,0.983589490738103
727,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Down,0.876393301275659,0.983589490738103
728,WP_NRF2ARE_REGULATION,20,Down,0.87675191243203,0.983589490738103
729,WP_MACROPHAGE_MARKERS,8,Down,0.877326961934701,0.983589490738103
730,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,15,Up,0.878638254680592,0.983589490738103
731,WP_PROLACTIN_SIGNALING,69,Down,0.878907713980655,0.983589490738103
732,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.879291739694519,0.983589490738103
733,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.881674701264607,0.983589490738103
734,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.885070015981011,0.983589490738103
735,WP_IL9_SIGNALING,15,Up,0.885594662207104,0.983589490738103
736,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Down,0.885735126976824,0.983589490738103
737,WP_ESTROGEN_METABOLISM_WP5276,9,Up,0.886296160673212,0.983589490738103
738,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Down,0.886883360068417,0.983589490738103
739,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,14,Up,0.887464347230603,0.983589490738103
740,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.890768572288483,0.983589490738103
741,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.891124037493196,0.983589490738103
742,WP_KLEEFSTRA_SYNDROME,25,Down,0.895459749847003,0.983589490738103
743,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.896940399952003,0.983589490738103
744,WP_IL6_SIGNALING,38,Up,0.897362599401847,0.983589490738103
745,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Down,0.898006466998389,0.983589490738103
746,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.898052755716731,0.983589490738103
747,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.899062727660404,0.983589490738103
748,WP_HISTONE_MODIFICATIONS,37,Down,0.903229498488146,0.983589490738103
749,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.903862383944819,0.983589490738103
750,WP_METASTATIC_BRAIN_TUMOR,6,Down,0.904528136757859,0.983589490738103
751,WP_IL11_SIGNALING,40,Up,0.904719794269777,0.983589490738103
752,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Up,0.905423158842085,0.983589490738103
753,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Down,0.905428393086045,0.983589490738103
754,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Down,0.906372067026278,0.983589490738103
755,WP_ADIPOGENESIS,86,Down,0.907435865336149,0.983589490738103
756,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.909092616052281,0.983589490738103
757,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,57,Down,0.90937414573429,0.983589490738103
758,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,40,Down,0.913254136788282,0.983589490738103
759,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Up,0.913778640757647,0.983589490738103
760,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.91543049235608,0.983589490738103
761,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.916257903607065,0.983589490738103
762,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,12,Up,0.916978063324586,0.983589490738103
763,WP_PHOSPHOINOSITIDES_METABOLISM,38,Down,0.918544070681148,0.983589490738103
764,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.919492281795702,0.983589490738103
765,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.919632128174444,0.983589490738103
766,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.919900674781719,0.983589490738103
767,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.920897145199055,0.983589490738103
768,WP_AMINO_ACID_METABOLISM,59,Down,0.921765209080944,0.983589490738103
769,WP_MIRNA_BIOGENESIS,6,Up,0.922699695110569,0.983589490738103
770,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.923061797064065,0.983589490738103
771,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.924479463534263,0.983589490738103
772,WP_CILIARY_LANDSCAPE,185,Down,0.924568329375861,0.983589490738103
773,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.925202090054576,0.983589490738103
774,WP_GLUTATHIONE_METABOLISM,10,Down,0.926820707920089,0.983589490738103
775,WP_DRAVET_SYNDROME,14,Up,0.927754184788264,0.983589490738103
776,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.928546769845216,0.983589490738103
777,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.930315110372058,0.984194363868509
778,WP_B_CELL_RECEPTOR_SIGNALING,85,Up,0.933297371387588,0.986080256144726
779,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.936405590098013,0.987486801507949
780,WP_FOCAL_ADHESION,119,Down,0.939204340944641,0.987486801507949
781,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,0.940728026424952,0.987486801507949
782,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Up,0.941132898043554,0.987486801507949
783,WP_ATM_SIGNALING,34,Down,0.941718737909644,0.987486801507949
784,WP_JOUBERT_SYNDROME,71,Down,0.943212800425045,0.987486801507949
785,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Up,0.943350634876043,0.987486801507949
786,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Down,0.944431109233237,0.987486801507949
787,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Up,0.945440526504569,0.987486801507949
788,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.948660465646622,0.989592516194827
789,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,38,Up,0.951005782681633,0.98983589081188
790,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Up,0.954243702647039,0.98983589081188
791,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.955238769717356,0.98983589081188
792,WP_AUTOPHAGY,27,Up,0.955812458320984,0.98983589081188
793,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.960407900353816,0.98983589081188
794,WP_CYTOSINE_METHYLATION,7,Down,0.961216755786519,0.98983589081188
795,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.9612632478224,0.98983589081188
796,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,36,Up,0.96182559662142,0.98983589081188
797,WP_RAC1PAK1P38MMP2_PATHWAY,51,Down,0.961906513541717,0.98983589081188
798,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.963286511399876,0.98983589081188
799,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,20,Down,0.964138886952976,0.98983589081188
800,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Down,0.966635477273604,0.98983589081188
801,WP_BDNFTRKB_SIGNALING,26,Up,0.966675434898045,0.98983589081188
802,WP_BARDETBIEDL_SYNDROME,65,Up,0.96679721527931,0.98983589081188
803,WP_HEPATITIS_B_INFECTION,116,Up,0.966956472411119,0.98983589081188
804,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.968967084360791,0.990177690650319
805,WP_ACUTE_VIRAL_MYOCARDITIS,65,Up,0.97008865410793,0.990177690650319
806,WP_UROTENSINIIMEDIATED_SIGNALING,48,Down,0.970904158958829,0.990177690650319
807,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.979749562713923,0.996994510778503
808,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Down,0.980014068989088,0.996994510778503
809,WP_ACE_INHIBITOR_PATHWAY,5,Up,0.981606038392403,0.997379683014283
810,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.98433789079422,0.998723430082945
811,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Down,0.985358518001543,0.998723430082945
812,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Down,0.991471965044206,0.999486282174159
813,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Up,0.99180061109759,0.999486282174159
814,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Down,0.9925289728611,0.999486282174159
815,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.992850458637534,0.999486282174159
816,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Down,0.994535423378033,0.999486282174159
817,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.995613302357926,0.999486282174159
818,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.996874879285416,0.999486282174159
819,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.997135904076948,0.999486282174159
820,WP_7OXOC_AND_7BETAHC_PATHWAYS,18,Down,0.997856991240476,0.999486282174159
821,WP_ASPIRIN_AND_MIRNAS,8,Up,0.998270362122853,0.999486282174159
822,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.999862108344135,0.999862108344135
